Table 4 Fasting Glucose, Insulin and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)1
Parameter | Visit | Placebo N = 14 | 3 g/d BBG N = 15 | 6 g/d BBG N = 15 | p-value2 | Pairwise Comparisons3 |
|---|---|---|---|---|---|---|
Fasting Plasma Glucose (mg/dL) | Week 0 | 102.4 (2.4) | 103.7 (3.9) | 99.1 (2.3) | 0.775 (r) | 3 g/d: 0.977; 6 g/d: 0.833 |
Week 12 | 110.1 (4.4) | 112.0 (7.6) | 100.6 (3.1) | |||
Change | 7.6 (4.7) | 8.3 (7.3) | 1.5 (3.0) | 0.399 (r) | 3 g/d: 0.577; 6 g/d: 0.305 | |
Fasting Insulin (uIU/mL) | Week 0 | 6.5 (1.1) | 8.7 (1.6) | 8.3 (1.6) | 0.752 (r) | 3 g/d: 0.671; 6 g/d: 0.856 |
Week 12 | 8.6 (1.8) | 8.3(1.6) | 6.7 (1.3) | |||
Change | 2.1 (1.2) | -0.4 (.8) | -1.6 (1.0) | 0.014 (r) | 3 g/d: 0.091; 6 g/d: 0.008 | |
HOMA-IR | Week 0 | 1.7 (0.3) | 2.3 (0.5) | 2.1 (0.4) | 0.834 (r) | 3 g/d: 0.771; 6 g/d: 0.952 |
Week 12 | 2.4 (0.5) | 2.3 (0.5) | 1.7 (0.3) | |||
Change | 0.7 (0.3) | -0.0 (0.3) | -0.4 (0.3) | 0.025 (r) | 3 g/d: 0.130; 6 g/d: 0.014 | |
Matsuda Index | Week 0 | 16.0 (2.6) | 18.1 (4.1) | 16.7 (3.8) | ||
Week 12 | 14.1 (3.4) | 17.4 (4.7) | 17.5 (3.7) | |||
% Change | -13.4 (9.4) | -3.3 (10.9) | 18.1 (12.2) | 0.928 (r) | 3 g/d: 0.901; 6 g/d: 0.949 |